期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胰岛素泵强化治疗2型糖尿病疗效观察 被引量：7

下载PDF
导出
摘要 目的观察赖脯胰岛素注射液(优泌乐)和重组人胰岛素注射液(优泌林R)皮下持续输注治疗2型糖尿病患者的疗效和安全性。方法将52例经口服降糖药物控制不佳的2型糖尿病患者随机分为优泌乐组30例,给予优泌乐胰岛素泵持续皮下注入;优泌林R组22例,给予优泌林R胰岛素泵持续皮下注入,根据血糖水平调节胰岛素剂量,直至血糖达标。结果 2种方法均能有效控制高血糖,2组间胰岛素平均剂量没有差异(P>0.05),但优泌乐组能够更快地达标,而且低血糖的发生率更低,2组间比较有统计学差异(P<0.05)。结论优泌乐较优泌林R能更明显地降低2型糖尿病患者餐后血糖,少低血糖风险,同时更易于为患者接受。
作者 朱近悦 喻明 徐碧林 夏娟
机构地区 上海中医药大学附属普陀医院
出处 《现代中西医结合杂志》 CAS 2010年第18期2254-2255,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 赖脯胰岛素 人胰岛素 2型糖尿病
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献6

  • 1卜石,邢小燕,王娜,赵文惠,杨文英.长效胰岛素联合口服降糖药治疗2型糖尿病的疗效与安全性[J].中国循证医学杂志,2004,4(7):464-467. 被引量：157
  • 2Alvarson M,Sundkvist G,Larger I,et al.Benifitcial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in resently diagnosed type 2 diabetic patients[J].Diabetes Care,2003,26:2231-2237.
  • 3Jermendy G.Short acting insulin analogues for treating diabetic patients with CSII (continuous subcutaneous insulin infusion)[J].Orv Hetil,2006,147(46):2223-2226.
  • 4Lenhard MJ,Reeves GD.Continuous subcutaneous insulin infusion a com-prehensive review of insulin pumptherapy[J].Arch Intem Med,2001,161(19):2293-2300.
  • 5冯尤健,陈祥彪,刘桑燕,巫晓强,刘碧玲.新诊断2型糖尿病患者两种短期胰岛素强化治疗的疗效比较[J].中国糖尿病杂志,2008,16(1):40-41. 被引量：35
  • 6Lee P,Kinsella J,Borkman M,et al.Bilateral pleural effusions,ascites,and facial and peripheral oedema in a 19-year-old woman 2 weeks following commencement of insulin lispro and detemir-an unusual presentation of insulin oedema[J].Diabet Med,2007,24(11):1282-1285.

二级参考文献13

  • 1Riddle MC,Rosenstock J,Gerich J.Insulin Glargine 4002 Study Investigators.The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J].Diabetes Care,2003; 26(11):3 080-3 086.
  • 2HOE 901/3002 Study Group.Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes[J].Diabetes Care,2000; 23(8):1 130-1 136
  • 3UKPDS Study Group.Stratton IM,Adler AI,Neil HAW,Matthews DR,Manley SE,Cull CA,Hadden D,Turner RC,Holman RR.Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes:prospective observational study (UKPDS 35) [J].BMJ,20
  • 4Wright A,Burden ACF,Paisey RB.Sulfonylurea Inadequacy:Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)[J].Diabetes Care,2002; 25(2):330-336
  • 5Turner RC,Cull CA,Frighi V,Holman RR.Glycemic control with diet,sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus:progressive requirement for multiple therapies (UKPDS 49).UK Prospective Diabetes Study (UKPDS) Group[J].JAMA,1999;
  • 6UKPDS Study Group.Klein R,Klein BE,Moss SE.Relation of glycemic control to diabetic microvascular complications indiabetes mellitus[J].Ann Intern Med,1996;124(1 Pt 2):90-96
  • 7UKPDS Study Group.Overview of six years' therapy of type 2 diabetes-a progressive disease (UKPDS 16)[J].Diabetes Care,1995; 44(11):1 249-1 258
  • 8Matthaei S.Endocrine review[M],21(6):585-618
  • 9Ilkova H, Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 10Galicka-Latala D, Solnica B, Bien AI. Personal insulin pumps for intensive insulin therapy of diabetes. Przegl Lek, 1999,56:357-361.

共引文献190

同被引文献30

引证文献7

二级引证文献8

现代中西医结合杂志
2010年 第18期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部